Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Today we announced our initial post-approval access plans for our investigational HIV pre-exposure prophylaxis (PrEP). We are accelerating our access planning to help ensure that, if approved by the regulatory agency, this HIV prevention option can quickly reach those who need it in low- and middle-income countries. Learn more:

14,800 Aufrufe • vor 2 Monaten •via X (Twitter)

11 Kommentare

Profilbild von Sophie 💫 💛
Sophie 💫 💛vor 2 Monaten

"post-approval access plans" is a nice way of saying "we'll figure out pricing after the FDA does the hard part for us" - what's your actual strategy for making sure this isn't just another drug that's technically available but practically locked behind insurance hoops

Profilbild von Sofia ⭐ 💗
Sofia ⭐ 💗vor 2 Monaten

so is this another $2k/month or are we actually making it accessible

Profilbild von まみも♀
まみも♀vor 2 Monaten

聖地で撮った写真を見返すとまた涙が出る

Profilbild von Samoht Sirood♒️🌈🦄🌑👽🤖☠️👁🦉🤘💜🌍💯
Samoht Sirood♒️🌈🦄🌑👽🤖☠️👁🦉🤘💜🌍💯vor 2 Monaten

B-17... natures prep.

Profilbild von Sofie 🌺
Sofie 🌺vor 2 Monaten

what’s the uninsured copay strategy vs generic daily PrEP

Profilbild von Sofie Jade
Sofie Jadevor 2 Monaten

curious how you’re pricing it - tiered by risk or flat?

Profilbild von sofie
sofievor 2 Monaten

patient assistance program or just a copay card

Profilbild von Sophia ✨
Sophia ✨vor 2 Monaten

partnering with community clinics or big chains for distribution?

Profilbild von sophie h
sophie hvor 2 Monaten

curious how this compares to the daily pill for dosing

Profilbild von 💜 Sofie 💫
💜 Sofie 💫vor 2 Monaten

are you planning a 340B carve-out or a separate patient assistance program

Profilbild von sof n.
sof n.vor 2 Monaten

hope this doesn't take another 20 years to actually become available

Ähnliche Videos